Industry News
NHMRC research measures up, says report
The National Health and Medical Research Council (NHMRC) has released Measuring Up 2013 - a report which analyses and compares the publication output of NHMRC health and medical research funding with other Australian research. [ + ]
2014 BHP Billiton Science and Engineering Awards winners announced
The winners of the 2014 BHP Billiton Science and Engineering Awards were announced last week in Melbourne by the Chief Executive Officer of BHP Billiton, Andrew Mackenzie, and CSIRO Chief Executive, Megan Clark. [ + ]
Webinar on cloud computing in the science industry
Fronde is holding an introductory webinar about business cloud computing in 2014 and what this can mean for businesses in the science space. The webinar will be held on Wednesday 19 February from 9-9.30 am AEDT. [ + ]
Alchemia names new chairman
Alchemia (ASX:ACL) has selected a permanent successor to the post of chairman, following the retirement of long-serving chair Mel Bridges last year. [ + ]
AusBiotech responds to the review of employee share schemes
AusBiotech has responded on behalf of its members to the federal government's review of employee share schemes (ESS) for start-ups, making both direct and written submissions to the review last week. [ + ]
NHS awards cytogenetics tender to OGT
Oxford Gene Technology (OGT), a provider of innovative genetics research and biomarker solutions to advance molecular medicine, has been awarded a tender by the UK National Health Service (NHS) for the supply of oligo-based arrays for cytogenetics. [ + ]
Nanoplastic catches cancer cells
A simple method for capturing cancer cells in the blood could improve patient prognosis and response to treatment. [ + ]
Million-dollar grant to roll out HIV test
An easy-to-use HIV diagnostic has received funding of US$1.6 million to kickstart field studies. [ + ]
Prima wins more approvals for ovarian cancer trial
Regulatory agencies from Latvia, Lithuania, Ukraine and Belarus have joined their Belgian counterpart in signing off on Prima BioMed's (ASX:PRR) CAN-004 trial. [ + ]
Oldest pathogen genome reveals cause of devastating pandemics
An international collaboration of scientists has revealed that two of the world's most devastating plagues were caused by distinct versions of the same pathogen. [ + ]
Viralytics to get new US oncolytic virus patent
Viralytics (ASX:VLA) has been granted a notice of allowance for a US patent covering anticancer candidate Cavatak and the family of oncolytic viruses to which it belongs. [ + ]
TGA seeks experts for advisory roles
The Therapeutic Goods Administration (TGA) is seeking expressions of interest from experts in relevant clinical or scientific fields who want to contribute to the regulation of therapeutic goods in Australia. [ + ]
Developing single-dose vaccines for cattle
Researchers at The University of Queensland (UQ) are working on a single-dose (shelf-stable) vaccine that could be used to prevent common cattle diseases and reduce vaccination costs. [ + ]
Capturing circulating cancer cells
Researchers at the Ian Wark Research Institute, located at the University of South Australia, have developed a new way to catch cancer cells circulating in a patient's blood. [ + ]
Samuel Sadoulet named president of Edmund Optics
Optical components provider Edmund Optics has appointed Samuel Sadoulet as its president. Sadoulet is currently chief operating officer of the company and will retain that title as he leads the company's corporate technology, global engineering and manufacturing operations. [ + ]